Insider Trading February 6, 2026

Alphatec EVP David Sponsel Sells $833,260 in ATEC Stock; Guidance and Results Draw Mixed Analyst Reactions

Sale executed under a pre-arranged 10b5-1 plan as Alphatec posts decelerating Q4 growth and issues 2026 revenue guidance below historical pace

By Nina Shah ATEC
Alphatec EVP David Sponsel Sells $833,260 in ATEC Stock; Guidance and Results Draw Mixed Analyst Reactions
ATEC

David Sponsel, Executive Vice President of Sales at Alphatec Holdings Inc (NASDAQ: ATEC), sold 60,425 shares on February 5, 2026, for $833,260 under a 10b5-1 trading plan. The transaction occurred at a weighted average price of $13.79, within a $13.43 to $14.22 range, while the stock trades near $13.83. Alphatec reported preliminary Q4 and full-year 2025 results that modestly beat expectations, though Q4 revenue growth decelerated. Management set 2026 revenue guidance at $890 million, or 17% growth, below the company’s historical pace of over 20% and slightly above analyst consensus of $886.9 million. Analysts remain largely constructive, with several firms maintaining Buy ratings despite a pullback in the stock year-to-date.

Key Points

  • David Sponsel sold 60,425 ATEC shares on February 5, 2026, for $833,260 under a 10b5-1 plan; weighted average sale price was $13.79 (range $13.43 to $14.22).
  • Alphatec reported preliminary Q4 and full-year 2025 results that slightly exceeded expectations, with Q4 revenue growth decelerating but remaining above historical averages; 2026 revenue guidance is $890 million (17% growth).
  • Analysts largely maintain Buy ratings despite the stock’s 34% year-to-date decline; InvestingPro data shows the stock trading near Fair Value and forecasts profitability this year.

Transaction details

Alphatec Holdings Inc (NASDAQ: ATEC) Executive Vice President of Sales David Sponsel sold 60,425 shares of common stock on February 5, 2026, receiving total proceeds of $833,260. The block of shares was sold under a pre-arranged 10b5-1 trading plan adopted on June 12, 2025. The trades were executed at a weighted average price of $13.79, with individual transactions occurring between $13.43 and $14.22.

At the time of the sale, Alphatec’s shares were trading at $13.83, marginally above the weighted average sale price.


Post-transaction ownership

Following the disposition, Sponsel directly holds 349,500 shares of Alphatec common stock. That total reflects shares acquired through the company’s employee stock purchase plan and incorporates the forfeiture of previously reported restricted stock units.


Company performance and outlook

Alphatec reported strong revenue momentum on a trailing 12-month basis, with revenue growth of 27%. Despite that growth, the stock has declined 34% year-to-date.

The company released preliminary fourth quarter and full-year 2025 results that slightly outperformed expectations. While revenue continued to grow in Q4, management acknowledged a slowing in the pace of revenue expansion relative to prior quarters; nevertheless, Q4 revenue growth remained above Alphatec’s historical average.

Management issued revenue guidance for 2026 of $890 million, equating to 17% year-over-year growth. That guidance is below the firm’s historical growth rate of more than 20%, a point that has raised investor concern, although the $890 million target is modestly above the current analyst consensus of $886.9 million. Alphatec is scheduled to report formal earnings on February 24, which could offer additional clarity on its near-term trajectory.


Analyst responses and valuation context

InvestingPro data indicates Alphatec is trading close to its Fair Value and that analysts expect the company to return to profitability within the year despite recent losses. Several brokerages updated or reiterated coverage in the wake of the company’s preliminary results and guidance.

  • TD Cowen lowered its price target for Alphatec to $20.00 from $27.00, citing valuation concerns, while retaining a Buy rating.
  • Canaccord Genuity reaffirmed a Buy rating with a $25.00 price target.
  • Freedom Capital Markets also maintained a Buy rating and a $25.00 price target, despite the stock’s significant decline.
  • Stifel characterized the Q4 revenue growth deceleration as a function of prior strong performance rather than evidence of new negative developments.

InvestingPro additionally provides a comprehensive Research Report for ATEC and over 1,400 other U.S. stocks, and the platform’s Fair Value tools are cited as available to assess whether the shares represent a bargain at current levels.


What to watch next

Investors will be focused on the company’s formal earnings release on February 24 for further detail on revenue trends, profitability drivers, and any commentary around execution against the 2026 revenue target. Given the combination of an insider sale, decelerating quarter-over-quarter growth, and guidance below historical rates, market participants may weigh near-term uncertainty against longer-term growth assumptions and the analyst outlook for a return to profitability.

Risks

  • 2026 revenue guidance of $890 million implies 17% growth, below Alphatec’s historical pace of over 20%, which has raised investor concern - this impacts the healthcare and medtech sectors.
  • The company’s Q4 revenue growth decelerated compared with earlier quarters, creating uncertainty around near-term revenue trajectory and investor sentiment in medical technology stocks.
  • The stock is down 34% year-to-date, which may reflect market skepticism and could increase volatility around upcoming earnings and guidance updates.

More from Insider Trading

Clean Harbors Director Executes $204,802 Sale as Company Reports Strong Q4 and Pushes M&A Agenda Feb 21, 2026 Clean Harbors Executive Disposes Nearly $1.0M in Stock as Company Posts Strong Q4 Feb 21, 2026 Clean Harbors CFO Disposes $784K in Shares as Company Reports Strong Quarter and Pursues Acquisition Feb 21, 2026 Travelers Executive Vice President Records $1.74 Million Share Sale as Company Posts Strong Quarter Feb 21, 2026 Genasys Director Buys $50,404 of Stock; Company Reports Mixed Q1 Results Feb 21, 2026